Skip to main content
. 2015 Jun 11;34(2):595–602. doi: 10.3892/or.2015.4051

Table I.

Correlation between the clinicopathological characteristics and miR-153 expression in PDAC.

Characteristics Total no. of patients, n=80 miR-153 expression
P-value
Low High
Age (years) 0.348
 ≤60 28 16 12
 >60 52 24 28
Gender 0.813
 Male 27 14 13
 Female 53 26 27
Tumor margin 0.179
 Negative 38 16 22
 Positive 42 24 18
Lymph node metastasis 0.014a
 Absent 43 16 27
 Present 37 24 13
Tumor size (cm) 0.446
 ≤2 21 9 12
 >2 59 31 28
Neural invasion 0.496
 Negative 33 15 18
 Positive 47 25 22
Tumor recurrence 0.004a
 None 39 13 26
 Local and regional metastasis 41 27 14
Tumor differentiation 0.024a
 Wel/moderate 34 12 22
 Poor 46 28 18
Tumor stage 0.001a
 I+II 39 12 27
 III+IV 41 28 13
a

Statistically significant. PDAC, pancreatic ductal adenocarcinoma.